People · Operator

Tod J. Linstroth

Named in public records as an officer, director or promoter · active 2017–2017 · Other Health Care

1
Companies
1
Filings
$4.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
ImageMoverMD, Inc.Other Health CareSeed$4.4M$39.7M2017
Operator network

Tod J. Linstroth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mark Bakken · 24 companies · 1 sharedMark BakkenWILLIAM SCHMIDT · 7 companies · 1 sharedWILLIAM SCHMIDTDarcey Nett · 2 companies · 1 sharedDarcey NettMark J. Bakken · 2 companies · 1 sharedMark J. BakkenDarcey J. Nett · 1 companies · 1 sharedDarcey J. NettGabriela Frazer · 1 companies · 1 sharedGabriela FrazerGary J Wendt · 1 companies · 1 sharedGary J WendtGary Wendt · 1 companies · 1 sharedGary WendtJames J Berbee · 1 companies · 1 sharedJames J BerbeeK. Thomas Pickard · 1 companies · 1 sharedK. Thomas PickardLon J Sprecher · 1 companies · 1 sharedLon J SprecherMark J Gehring · 1 companies · 1 sharedMark J GehringRichard J Bruce · 1 companies · 1 sharedRichard J BruceTod Linstroth · 1 companies · 1 sharedTod LinstrothWill Robus · 1 companies · 1 sharedWill RobusImageMoverMD, Inc. · $4.4M raisedImageMoverMD, Inc.Tod J. LinstrothTL
Tod J. Linstroth Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Tod J. Linstroth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mark Bakken124
WILLIAM SCHMIDT17
Mark J. Bakken12
Darcey Nett12
Lon J Sprecher11
Richard J Bruce11
Mark J Gehring11
Will Robus11
Gary Wendt11
Gabriela Frazer11
Tod Linstroth11
Darcey J. Nett11
Gary J Wendt11
K. Thomas Pickard11
James J Berbee11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.